Erratum: GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils (Cell Research (2011) 21 (1452-1469) DOI: 10.1038/cr.2011.60);GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils

Cell Research

Volumn 21, Issue 10, 2011, Pages 1452-1469

  Balenga, Nariman A B ^a   Aflaki, Elma ^a   Kargl, Julia ^a   Platzer, Wolfgang ^a   Schröder, Ralf ^b   Blättermann, Stefanie ^b   Kostenis, Evi ^b   Brown, Andrew J ^c   Heinemann, Akos ^a   Waldhoer, Maria ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF BONN   (Germany)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cdc42; chemotaxis; GPR55; Rac2; ROS production

Indexed keywords

EID: 80053652832     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2011.169     Document Type: Erratum

References (76)

1. Chakravarti A, Allaeys I, Poubelle PE. Neutrophils and immunity: is it innate or acquired? Med Sci (Paris) 2007;23:862-867.
2. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006;6:173-182. (Pubitemid 43290987)
3. Witko-Sarsat V, Rieu P, scamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000;80:617-653.
4. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005;6:1182-1190. (Pubitemid 43045626)
5. Monk PN, Scola AM, Madala P, Fairlie DP. Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol 2007;152:429-448. (Pubitemid 47585036)
6. Premack BA, Schall TJ. Chemokine receptors: gateways to inflammation and infection. Nat Med 1996;2:1174-1178. (Pubitemid 26375391)
7. Di M, V, Bisogno T, De PL, et al. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 1999;264:258-267. (Pubitemid 29385890)
8. Gauthier KM, Baewer DV, Hittner S, et al. Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. Am J Physiol Heart Circ Physiol 2005;288:H1344-H1351. (Pubitemid 40270043)
9. Buckley NE. The peripheral cannabinoid receptor knockout mice: an update. Br J Pharmacol 2008;153:309-318.
10. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993;365:61-65. (Pubitemid 23305569)
11. Sugiura T, Kondo S, Kishimoto S, et al. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J Biol Chem 2000;275:605-612. (Pubitemid 30039024)
12. Kishimoto S, Gokoh M, Oka S, et al. 2-arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. J Biol Chem 2003;278:24469-24475. (Pubitemid 37548598)
13. Zhao Q, He Z, Chen N, et al. 2-Arachidonoylglycerol stimulates activator protein-1-dependent transcriptional activity and enhances epidermal growth factor-induced cell transformation in JB6 P+ cells. J Biol Chem 2005;280:26735-26742. (Pubitemid 41040706)
14. Kurihara R, Tohyama Y, Matsusaka S, et al. Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils. J Biol Chem 2006;281:12908-12918. (Pubitemid 43855384)
15. Ryberg E, Larsson N, Sjogren S, et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 2007;152:1092-1101. (Pubitemid 350166046)
16. Sharir H, Abood ME. Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther 2010;126:301-313.
17. Pietr M, Kozela E, Levy R, et al. Differential changes in GPR55 during microglial cell activation. FEBS Lett 2009;583:2071-2076.
18. Henstridge CM, Balenga NA, Ford LA, et al. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB J 2009;23:183-193.
19. Lauckner JE, Jensen JB, Chen HY, et al. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci USA 2008;105:2699-2704. (Pubitemid 351520576)
20. Kapur A, Zhao P, Sharir H, et al. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem 2009;284:29817-29827
21. Henstridge CM, Balenga NA, Schroder R, et al. GPR55 ligands promote receptor coupling to multiple signaling pathways. Br J Pharmacol 2010;160:604-614.
22. Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T. Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 2007;362:928-934. (Pubitemid 47390663)
23. Oka S, Toshida T, Maruyama K, et al. 2-Arachidonoyl-snglycero-3- phosphoinositol: a possible natural ligand for GPR55. J Biochem 2009;145:13-20.
24. Corda D, Iurisci C, Berrie CP. Biological activities and metabolism of the lysophosphoinositides and glycerophosphoinositols. Biochim Biophys Acta 2002;1582:52-69. (Pubitemid 34634111)
25. Falasca M, Iurisci C, Carvelli A, Sacchetti A, Corda D. Release of the mitogen lysophosphatidylinositol from H-Rastransformed fibroblasts; a possible mechanism of autocrine control of cell proliferation. Oncogene 1998;16:2357-2365. (Pubitemid 28226883)
26. Falasca M, Corda D. Elevated levels and mitogenic activity of lysophosphatidylinositol in k-ras-transformed epithelial cells. Eur J Biochem 1994;221:383-389. (Pubitemid 24120583)
27. Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 2005;5:400-411. (Pubitemid 40685989)
28. Varga K, Wagner JA, Bridgen DT, Kunos G. Platelet-and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 1998;12:1035-1044. (Pubitemid 28359585)
29. Zoeller RA, Wightman PD, Anderson MS, Raetz CR. Accumulation of lysophosphatidylinositol in RAW 264.7 macrophage tumor cells stimulated by lipid A precursors. J Biol Chem 1987;262:17212-17220.
30. Emilsson A, Sundler R. Differential activation of phosphatidylinositol deacylation and a pathway via diphosphoinositide in macrophages responding to zymosan and ionophore A23187. J Biol Chem 1984;259:3111-3116. (Pubitemid 14162552)
31. McHugh D, Tanner C, Mechoulam R, Pertwee RG, Ross RA. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. Mol Pharmacol 2008;73:441-450. (Pubitemid 351159214)
32. Steffens S, Veillard NR, Arnaud C, et al. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 2005;434:782-786. (Pubitemid 44739523)
33. Jorda MA, Verbakel SE, Valk PJ, et al. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 2002;99:2786-2793. (Pubitemid 34525366)
34. Walter L, Franklin A, Witting A, et al. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 2003;23:1398-1405. (Pubitemid 36258918)
35. Oka S, Ikeda S, Kishimoto S, et al. 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. J Leukoc Biol 2004;76:1002-1009. (Pubitemid 39458711)
36. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314. (Pubitemid 24046692)
37. Bokoch GM. Regulation of innate immunity by Rho GTPases. Trends Cell Biol 2005;15:163-171. (Pubitemid 40332539)
38. Carstanjen D, Yamauchi A, Koornneef A, et al. Rac2 regulates neutrophil chemotaxis, superoxide production, and myeloid colony formation through multiple distinct effector pathways. J Immunol 2005;174:4613-4620.
39. Diebold BA, Fowler B, Lu J, Dinauer MC, Bokoch GM. Antagonistic cross-talk between Rac and Cdc42 GTPases regulates generation of reactive oxygen species. J Biol Chem 2004;279:28136-28142. (Pubitemid 38900087)
40. Ford LA, Roelofs AJ, navi-Goffer S, et al. A role for L-alphalysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells. Br J Pharmacol 2010;160:762-771.
41. Whyte LS, Ryberg E, Sims NA, et al. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci USA 2009;106:16511-16516.
42. Maestroni GJ. The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein. FASEB J 2004;18:1914-1916. (Pubitemid 39602282)
43. Smith DM, Waite M. Phosphatidylinositol hydrolysis by phospholipase A2 and C activities in human peripheral blood neutrophils. J Leukoc Biol 1992;52:670-678. (Pubitemid 23016042)
44. Zhelev D V, Alteraifi A. Signaling in the motility responses of the human neutrophil. Ann Biomed Eng 2002;30:356-370. (Pubitemid 34690559)
45. Bouaboula M, Rinaldi M, Carayon P, et al. Cannabinoid-receptor expression in human leukocytes. Eur J Biochem 1993;214:173-180. (Pubitemid 23168532)
46. Galiegue S, Mary S, Marchand J, et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995;232:54-61.
47. Miller AM, Stella N. CB2 receptor-mediated migration of immune cells: it can go either way. Br J Pharmacol 2008;153:299-308.
48. Waldeck-Weiermair M, Zoratti C, Osibow K, et al. Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptortriggered repression. J Cell Sci 2008;121:1704-1717. (Pubitemid 351911827)
49. Schroder R, Janssen N, Schmidt J, et al. Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements. Nat Biotechnol 2010;28:943-949.
50. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565-568. (Pubitemid 28207705)
51. Van KA, Wong K, Knight ZA, et al. To stabilize neutrophil polarity, PIP3 and Cdc42 augment RhoA activity at the back as well as signals at the front. J Cell Biol 2006;174:437-445. (Pubitemid 44156773)
52. Quinn MT, Gauss KA. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J Leukoc Biol 2004;76:760-781. (Pubitemid 39313712)
53. Dong X, Mo Z, Bokoch G, et al. P-Rex1 is a primary Rac2 guanine nucleotide exchange factor in mouse neutrophils. Curr Biol 2005;15:1874-1879. (Pubitemid 41501524)
54. Welch HC, Condliffe AM, Milne LJ, et al. P-Rex1 regulates neutrophil function. Curr Biol 2005;15:1867-1873. (Pubitemid 41501523)
55. Mitchell T, Lo A, Logan MR, Lacy P, Eitzen G. Primary granule exocytosis in human neutrophils is regulated by Racdependent actin remodeling. Am J Physiol Cell Physiol 2008;295:C1354-C1365. (Pubitemid 352790350)
56. Foxman EF, Kunkel EJ, Butcher EC. Integrating conflicting chemotactic signals. The role of memory in leukocyte navigation. J Cell Biol 1999;147:577-588.
57. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back. Science 2003;302:1704-1709. (Pubitemid 37505725)
58. Wong K, Van KA, Bourne HR. PDZRhoGEF and myosin II localize RhoA activity to the back of polarizing neutrophillike cells. J Cell Biol 2007;179:1141-1148. (Pubitemid 350277734)
59. Xu J, Wang F, Van KA, et al. Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils. Cell 2003;114:201-214. (Pubitemid 36936914)
60. Oka S, Kimura S, Toshida T, et al. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells. J Biochem 2010;147:671-678.
61. Glass M, Northup JK. Agonist selective regulation of G proteins by cannabinoid CB (1) and CB (2) receptors. Mol Pharmacol 1999;56:1362-1369.
62. Jbilo O, Derocq JM, Segui M, Le FG, Casellas P. Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60. FEBS Lett 1999;448:273-277. (Pubitemid 29168502)
63. Abdel-Latif D, Steward M, Macdonald DL, et al. Rac2 is critical for neutrophil primary granule exocytosis. Blood 2004;104:832-839. (Pubitemid 38970582)
64. Koh AL, Sun CX, Zhu F, Glogauer M. The role of Rac1 and Rac2 in bacterial killing. Cell Immunol 2005;235:92-97. (Pubitemid 41597472)
65. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. The small GTP-binding protein rac regulates growth factorinduced membrane ruffling. Cell 1992;70:401-410.
66. Kozma R, Ahmed S, Best A, Lim L. The Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts. Mol. Cell Biol 1995;15:1942-1952.
67. Rosenfeldt H, Castellone MD, Randazzo PA, Gutkind JS. Rac inhibits thrombin-induced Rho activation: evidence of a Pakdependent GTPase crosstalk. J Mol Signal 2006;1:8.
68. Nimnual AS, Taylor LJ, Bar-Sagi D. Redox-dependent downregulation of Rho by Rac. Nat Cell Biol 2003;5:236-241. (Pubitemid 36322251)
69. Zhang B, Zheng Y. Negative regulation of Rho family GT-Pases Cdc42 and Rac2 by homodimer formation. J Biol Chem 1998;273:25728-25733. (Pubitemid 28475796)
70. Gomez-Cambronero J, Frye T, Baumann M. Ribosomal p70S6K basal activity increases upon induction of differentiation of myelomonocytic leukemic cell lines HL60, AML14 and MPD. Leuk Res 2004;28:755-762. (Pubitemid 38639743)
71. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
72. Schratl P, Heinemann A. Differential involvement of Ca2+ and actin flament in leukocyte shape change. Pharmacology 2009;83:131-140.
73. Sturm EM, Schratl P, Schuligoi R, et al. Prostaglandin E2 inhibits eosinophil Trafficking through E-prostanoid 2 receptors. J Immunol 2008;181:7273-7283.
74. Tan W, Martin D, Gutkind JS. The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4. J Biol Chem 2006;281:39542-39549. (Pubitemid 46041914)
75. Waldhoer M, Kledal TN, Farrell H, Schwartz TW. Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J Virol 2002;76:8161-8168. (Pubitemid 34809070)
76. Schroder R, Merten N, Mathiesen JM, et al. The C-terminal tail of CRTH2 is a key molecular determinant that constrains Galphai and downstream signaling cascade activation. J Biol Chem 2009;284:1324-1336.